Potential Cause of Worse Outcomes Among Black Breast Cancer Patients Found
Medscape - December 12, 2022
Maja Oktay, M.D., Ph.D., comments on her study, presented at the San Antonio Breast Cancer Symposium, which suggests that Black women with a particular type of breast cancer have higher levels of a metastasis marker in their tumors after neoadjuvant chemotherapy, compared with white women. Dr. Oktay is co-leader of the Tuor Microenvironment and Metastasis Program at the NCI-designated Montefiore Einstein Cancer Center, professor of pathology at EInstein, and a pathologist at Montefiore.
Additional coverage includes The ASCO Post
Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
New England Journal of Medicine - December 21, 2017
An editorial highlights research by Drs. Maja Oktay, George Karagiannis, and John Condeelis on the mechanism by which some breast cancer tumor cells resist chemotherapy and go on to metastasize. Dr. Oktay is professor of pathology; Dr. Condeelis is the Judith & Burton P. Resnick Chair in Translational Research and professor and co-chair of anatomy and structural biology; Dr. Karagiannis is a postdoctoral fellow